Side effects of sugar substitutes during intravenous administration.
D000818:Animals; D004285:Dogs; D005632:Fructose / Q000009:adverse effects* / Q000378:metabolism; D005947:Glucose / Q000009:adverse effects* / Q000378:metabolism; D005994:Glycerophosphates / Q000096:biosynthesis; D007263:Infusions, Parenteral; D007773:Lactates / Q000096:biosynthesis; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D010070:Oxalates / Q000378:metabolism; D051381:Rats; D013012:Sorbitol / Q000009:adverse effects / Q000378:metabolism; D013268:Stimulation, Chemical; D013402:Sugar Alcohols / Q000009:adverse effects*; D014280:Triglycerides / Q000096:biosynthesis; D014527:Uric Acid / Q000096:biosynthesis; D014882:Water-Electrolyte Balance / Q000187:drug effects; D014993:Xylitol / Q000009:adverse effects / Q000378:metabolism
D005994:Glycerophosphates; D007773:Lactates; D010070:Oxalates; D013402:Sugar Alcohols; D014280:Triglycerides; D014527:Uric Acid; D005632:Fructose; D013012:Sorbitol; D005947:Glucose; D014993:Xylitol